Iran medicine shortages spike as US sanctions choke drug supply

Iran medicine shortages have surged as U.S. sanctions tighten, leaving countless patients without essential treatments.

Iran medicine shortages: scope and impact

Official health data show a ↓ 18% contraction in pharmaceutical imports since the latest sanction round, while retail prices for critical antibiotics have climbed ↑ 12%.

“The situation is untenable for patients with chronic conditions,” warned Dr. Leila Ghorbani, director of Tehran’s central pharmacy.

Government response and industry resilience

Authorities assert the domestic manufacturing base can offset the gap, citing recent capacity expansions at two state‑run facilities. Analysts at Reuters note that the sanctions target both raw material imports and financial channels, amplifying supply chain fragility. The lingering effects of the pandemic have already strained Iran’s health budget, compounding the current crisis. While the sector faces unprecedented pressure, experts caution that without diplomatic relief the shortage could trigger a public‑health emergency.

Analysis by: Elena Rostova

Socio-Economic Trends Analyst